Back
Spyre Therapeutics Stock Predictions
Sponsored
SYRE
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
44
SYRE
Spyre Therapeutics
Last Price:
32.98
Seasonality Move:
2.92%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereSpyre Therapeutics Stock Forecast
- Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 78.1% based on the past 8 years of stock performance.
- Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
-
Is Spyre Therapeutics Stock Undervalued?
The current Spyre Therapeutics [SYRE] share price is $34.25. The Score for SYRE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - SYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Spyre Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 78.1% based on the past 8 years of stock performance.
Spyre Therapeutics Stock Rating
Sell
44
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics overpriced?
- Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Spyre Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com
52-Week Data
52-Week High:
47.97
52-Week Low:
2.66
Prediction Charts
Market Cap:
1.24B
Price in USD:
34.25
Volume:
175.6K
Beta:
2.61
Technical Analysis
SMA50:
36.35
SMA100:
29.33
SMA200:
21.16
52-Wk Change:
756.25%
Stock Predictions
-
Is Spyre Therapeutics stock public?
Yes, Spyre Therapeutics is a publicly traded company. -
What is the Spyre Therapeutics stock quote today?
The Spyre Therapeutics stock price is 34.25 USD today. -
How to buy Spyre Therapeutics stock online?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-18 | 34.22 | 35.61 | 36.67 | 33.58 |
Apr-19 | 34.10 | 32.28 | 35.40 | 31.97 |
Apr-22 | 33.00 | 33.29 | 34.39 | 32.00 |
Apr-23 | 33.35 | 34.21 | 35.88 | 32.42 |
Apr-24 | 34.17 | 32.99 | 34.50 | 32.20 |
Apr-25 | 32.44 | 32.47 | 33.23 | 31.27 |
Apr-26 | 32.63 | 33.56 | 34.31 | 32.50 |
Apr-29 | 34.03 | 34.89 | 35.85 | 33.41 |
Apr-30 | 34.93 | 33.12 | 36.65 | 32.70 |
May-1 | 33.01 | 33.86 | 34.39 | 31.39 |
May-2 | 35.22 | 36.28 | 36.98 | 33.80 |
May-3 | 37.00 | 35.78 | 39.04 | 35.17 |
May-6 | 35.97 | 35.68 | 37.00 | 34.98 |
May-7 | 35.73 | 34.25 | 35.91 | 33.40 |
Spyre Therapeutics Earnings
Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Spyre Therapeutics Forecast Revenue Growth
Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.42 per share, an increase this year of $10.15 per share, and a decrease next year of $0.08 per share.
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.